Steven Miller's most recent trade in Warby Parker Inc - Ordinary Shares - Class A was a trade of 28,475 Class A Common Stock done . Disclosure was reported to the exchange on Sept. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 28,475 | 248,875 | - | 0 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.55 per share. | 03 Sep 2025 | 15,752 | 233,123 | - | 25.6 | 402,464 | Class A Common Stock |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 10,554 | 102,026 | - | - | Restricted Stock Units | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 8,879 | 50,319 | - | - | Restricted Stock Units | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 5,644 | 77,134 | - | - | Restricted Stock Units | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 3,398 | 0 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.28 per share. | 26 Aug 2025 | 115,000 | 949,663 (0%) | 0% | 20.3 | 2,332,200 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 26 Aug 2025 | 115,000 | 1,064,663 (1%) | 0% | 2.2 | 257,600 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2025 | 115,000 | 1,409,509 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 26 Aug 2025 | 110,000 | 1,059,663 (1%) | 0% | 2.2 | 246,400 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2025 | 110,000 | 1,299,509 | - | - | Options to purchase common stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 30,175 | 237,092 | - | 0 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.48 per share. | 03 Jun 2025 | 16,692 | 220,400 | - | 21.5 | 358,544 | Class A Common Stock |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 10,555 | 112,580 | - | - | Restricted Stock Units | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 8,880 | 59,198 | - | - | Restricted Stock Units | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 5,644 | 82,778 | - | - | Restricted Stock Units | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 5,096 | 3,398 | - | - | Restricted Stock Units | |
| Bausch Health Companies Inc | Steven D. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 54,347 | 229,224 (0%) | 0% | 0 | Common Shares, No Par Value | |
| BrightSpring Health Services | Steven B. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 11,912 | 22,620 | - | 0 | Common Stock | |
| Steelcase Inc Ordinary Shares | Steven Douglas Miller | VP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 23,000 | 109,491 (0%) | 0% | - | Class A Common Stock | |
| Steelcase Inc Ordinary Shares | Steven Douglas Miller | VP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2025 | 18,720 | 91,986 (0%) | 0% | - | Class A Common Stock | |
| Steelcase Inc Ordinary Shares | Steven Douglas Miller | VP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.58 per share. | 25 Mar 2025 | 5,495 | 86,491 (0%) | 0% | 10.6 | 58,137 | Class A Common Stock |
| Big 5 Sporting Goods Corp | Steven G. Miller | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 22,000 | 118,461 (0%) | 0% | 0 | Common Stock, par value $.01 | |
| Big 5 Sporting Goods Corp | Steven G. Miller | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.99 per share. | 14 Mar 2025 | 8,218 | 110,243 (0%) | 0% | 1.0 | 8,136 | Common Stock, par value $.01 |
| Jetblue Airways Corp | Steven D. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 22,094 | 51,710 | - | - | Deferred Stock Units | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 90,303 | 90,303 | - | - | Restricted Stock Units | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 27,731 | 216,411 | - | 0 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 15,128 | 195,001 | - | 0 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 23.52 per share. | 03 Mar 2025 | 11,684 | 204,727 | - | 23.5 | 274,808 | Class A Common Stock |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 10,554 | 123,135 | - | - | Restricted Stock Units | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 8,880 | 68,078 | - | - | Restricted Stock Units | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.16 per share. | 03 Mar 2025 | 6,321 | 188,680 | - | 24.2 | 152,715 | Class A Common Stock |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 5,095 | 8,494 | - | - | Restricted Stock Units | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 1,881 | 88,422 | - | - | Restricted Stock Units | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 1,321 | 0 | - | - | Restricted Stock Units | |
| Steelcase Inc Ordinary Shares | Steven Douglas Miller | VP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.16 per share. | 28 Feb 2025 | 3,713 | 73,266 (0%) | 0% | 12.2 | 45,150 | Class A Common Stock |
| Big 5 Sporting Goods Corp | Steven G. Miller | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 65,000 | 65,000 | - | - | Employee Stock Option (right to buy) | |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 13,667 | 949,663 (0%) | 0% | - | Common stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 13,667 | 1,524,509 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 14,000 | 935,996 (0%) | 0% | - | Common stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 14,000 | 1,538,176 | - | - | Restricted Stock Units | |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.01 per share. | 13 Dec 2024 | 235,000 | 921,996 (0%) | 0% | 4.0 | 942,350 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2024 | 235,000 | 1,552,176 | - | - | Options to purchase common stock | |
| Warby Parker Inc Ordinary | Miller Steven | Chief Financial Officer | 11 Dec 2024 | 7,016 | 182,130 | - | 23.9 | 167,332 | Class A Common Stock | |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 50,000 | 1,787,176 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Sale of securities on an exchange or to another person at price $ 21.93 per share. | 09 Dec 2024 | 50,000 | 686,996 (0%) | 0% | 21.9 | 1,096,350 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.01 per share. | 09 Dec 2024 | 50,000 | 736,996 (0%) | 0% | 4.0 | 200,500 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 11,872 | 686,996 (0%) | 0% | - | Common stock, par value $0.001 per share | |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 11,872 | 1,837,176 | - | - | Restricted Stock Units | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 03 Dec 2024 | 26,511 | 203,999 | - | 0 | Class A Common Stock | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 03 Dec 2024 | 14,853 | 189,146 | - | 22.6 | 335,826 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 03 Dec 2024 | 10,555 | 133,689 | - | - | Restricted Stock Units | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 03 Dec 2024 | 8,879 | 76,958 | - | - | Restricted Stock Units | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 03 Dec 2024 | 5,096 | 13,589 | - | - | Restricted Stock Units | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 03 Dec 2024 | 1,981 | 1,321 | - | - | Restricted Stock Units | ||
| Dana Inc | Steven D. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2024 | 126 | 425 | - | - | Dividend Equivalent Rights | |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 202,958 | 1,824,247 | - | - | Options to purchase common stock | |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 24,801 | 1,849,048 | - | - | Restricted Stock Units | |
| BrightSpring Health Services | Steven B. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2024 | 10,708 | 10,708 | - | 0 | Common Stock | |
| Steelcase Inc Ordinary Shares | Steven Douglas Miller | VP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.92 per share. | 22 Sep 2024 | 3,522 | 76,979 (0%) | 0% | 12.9 | 45,504 | Class A Common Stock |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 11 Sep 2024 | 6,763 | 177,488 | - | 13.9 | 94,006 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Sep 2024 | 26,511 | 199,523 | - | 0 | Class A Common Stock | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Sep 2024 | 15,272 | 184,251 | - | 13 | 198,536 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Sep 2024 | 10,544 | 144,254 | - | - | Restricted Stock Units | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Sep 2024 | 8,880 | 85,837 | - | - | Restricted Stock Units | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Sep 2024 | 5,096 | 18,685 | - | - | Restricted Stock Units | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Sep 2024 | 1,981 | 3,302 | - | - | Restricted Stock Units | ||
| Dana Inc | Steven D. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2024 | 111 | 299 | - | - | Dividend Equivalent Rights | |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.26 per share. | 20 Aug 2024 | 50,000 | 775,124 (0%) | 0% | 20.3 | 1,013,050 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.58 per share. | 20 Aug 2024 | 50,000 | 675,124 (0%) | 0% | 20.6 | 1,029,250 | Common stock, par value $0.001 per share |
| Catalyst Pharmaceuticals Inc | Steven R. Miller | Chief Op. & Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.21 per share. | 20 Aug 2024 | 50,000 | 725,124 (0%) | 0% | 20.2 | 1,010,600 | Common stock, par value $0.001 per share |
| Jetblue Airways Corp | Steven D. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2024 | 23,519 | 23,519 | - | - | Deferred Stock Units | |
| Jetblue Airways Corp | Steven D. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2024 | 6,097 | 29,616 | - | - | Deferred Stock Units | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 11 Jun 2024 | 99,816 | 173,012 | - | 16.6 | 1,657,944 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 11 Jun 2024 | 99,816 | 0 | - | - | Stock Option (Right to Buy) | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 11 Jun 2024 | 99,816 | 272,828 | - | 13.4 | 1,332,544 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 11 Jun 2024 | 9,394 | 173,012 | - | 16.6 | 155,846 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Jun 2024 | 58,455 | 0 | - | - | Stock Option (Right to Buy) | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Jun 2024 | 58,455 | 225,334 | - | 12.3 | 721,919 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Jun 2024 | 58,455 | 166,879 | - | 16.5 | 965,326 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Jun 2024 | 26,511 | 193,390 | - | - | Class A Common Stock | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Jun 2024 | 15,709 | 166,879 | - | 17.0 | 267,619 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Jun 2024 | 10,984 | 182,406 | - | 16.7 | 183,103 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Jun 2024 | 10,601 | 0 | - | - | Stock Option (Right to Buy) | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Jun 2024 | 10,601 | 181,926 | - | 13.1 | 138,661 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Jun 2024 | 10,554 | 154,798 | - | - | Restricted Stock Units | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Jun 2024 | 8,880 | 94,717 | - | - | Restricted Stock Units | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Jun 2024 | 5,096 | 23,781 | - | - | Restricted Stock Units | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Jun 2024 | 1,981 | 5,283 | - | - | Restricted Stock Units | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Jun 2024 | 662 | 58,455 | - | - | Stock Option (Right to Buy) | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Jun 2024 | 662 | 182,588 | - | 12.4 | 8,176 | Class A Common Stock | |
| Dana Inc | Steven D. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 88 | 188 | - | - | Dividend Equivalent Rights | |
| Bausch Health Companies Inc | Steven D. Miller | Director | 17 May 2024 | 35,360 | 174,877 (0%) | 0% | 0 | Common Shares, No Par Value | ||
| Steelcase Inc Ordinary Shares | Steven Douglas Miller | VP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2024 | 18,000 | 80,501 (0%) | 0% | - | Class A Common Stock | |
| Dana Inc | Steven D. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2024 | 100 | 100 | - | - | Dividend Equivalent Rights | |
| Big 5 Sporting Goods Corp | Steven G. Miller | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 22,000 | 103,418 (0%) | 0% | 0 | Common Stock, par value $.01 | |
| Big 5 Sporting Goods Corp | Steven G. Miller | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.58 per share. | 14 Mar 2024 | 6,957 | 96,461 (0%) | 0% | 3.6 | 24,906 | Common Stock, par value $.01 |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 11 Mar 2024 | 24,225 | 166,879 | - | 12.0 | 290,216 | Class A Common Stock | |
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Mar 2024 | 21,159 | 199,812 | - | 0 | Class A Common Stock | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Mar 2024 | 8,880 | 103,597 | - | - | Restricted Stock Units | ||
| Warby Parker Inc Ordinary | Steven Miller | Chief Financial Officer | 06 Mar 2024 | 8,708 | 191,104 | - | 11.9 | 103,451 | Class A Common Stock |